Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Has results × Serotonin Syndrome × telotristat ethyl × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Serotonin Syndrome 2 Neuroendocrine Tumors 2 Pancreatic Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

telotristat ethyl 2 telotristat 1 pasireotide 1 lanreotide 1 alpha-methyltryptophan 1 Random Allocation 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03453489 2025-04-10

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

Barbara Ann Karmanos Cancer Institute

Phase 2 Completed

4 enrolled 7 charts

Serotonin Syndrome

NCT03223428 2024-07-24

RELAX

TerSera Therapeutics LLC

223 enrolled 16 charts

Neuroendocrine Tumors, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡